Clik here to view.
Promethera Biosciences Announces Investment by ITOCHU Corporation and a Broad...
MONT-SAINT-GUIBERT, Belgium & TOKYO Promethera Biosciences SA, a global innovator in cell-based medicines and liver diseases, today announced a strategic investment of EUR10 million by ITOCHU...
View ArticleClik here to view.
CANbridge Pharmaceuticals and GC Pharma Announce Greater China Licensing...
BEIJING & SHANGHAI CANbridge Pharmaceuticals Inc., a biopharmaceutical company developing innovative drug candidates to treat underserved medical conditions in China and other markets, and GC...
View ArticleClik here to view.
LifeMap Sciences, Tianjin Novogene and Shanghai Shanyi Announce Strategic...
ALAMEDA, Calif. LifeMap Sciences, Inc., a subsidiary of AgeX Therapeutics, Inc. (NYSE American: AGE) announced today that Tianjin Novogene Medical Laboratory, LifeMap, and Shanghai Shanyi today...
View ArticleClik here to view.
Metabolon任命Michael Rasche为国际业务总裁
北卡罗来纳州罗利和德国波茨坦 (美国商业资讯)–代谢组学领域的全球领导者Metabolon今天宣布，Michael Rasche加盟公司担任国际业务总裁。Michael将向Metabolon总裁兼首席执行官Rohan Hastie汇报，并担任公司执行团队成员。他将负责Metabolon所有国际业务活动，重点关注客户与团队拓展。...
View ArticleClik here to view.
Clik here to view.
Prenetics Group Expands Its Digital Health Solutions with Acquisition of...
LONDON Prenetics, a leading global genetics and digital health company, has today announced it has acquired Kelaa App, the core product of Soma Analytics and associated assets. Founded in Germany in...
View ArticleClik here to view.
Repare Therapeutics Announces a Strategic Partnership Agreement With ONO...
MONTREAL & CAMBRIDGE, Mass. Repare Therapeutics, Inc., a privately held precision oncology company pioneering synthetic lethality to develop novel therapeutics that target specific...
View ArticleClik here to view.
H.I.G.Capital完成对Taconic Biosciences的收购
波士顿 –(美国商业资讯)–旗下管理着300亿美元股权资本的领先全球私募股权投资公司H.I.G.Capital (“H.I.G.”)欣然宣布，其附属公司之一已与Taconic Biosciences, Inc.（“Taconic”或“该公司”）管理团队合作支持该公司成长为制药、生物科技、合同研究组织(CRO)和学术研究行业领先的全球研究模型和服务提供商。...
View ArticleClik here to view.
キャピタルがタコニック・バイオサイエンシズの買収を完了
ボストン — （ビジネスワイヤ） — 運用資産300億ドルの世界的に有力なプライベート・エクイティ投資会社のHIGキャピタルは、当社投資先企業の1つがタコニック・バイオサイエンシズ（「タコニック」または「同社」）の経営陣と提携したことを発表します。製薬、バイオテクノロジー、CRO、学術研究機関に研究用のモデルとサービスを提供する世界一流企業としての同社の成長を支えることが目的です。...
View ArticleClik here to view.
SpeeDx开发呼吸道病毒复合检测
悉尼 (美国商业资讯)– SpeeDx Pty. Ltd.今天宣布向治疗用品管理局(TGA)报批PlexPCR® RespiVirus检测。公司预计将在澳大利亚2019年流感季节前获批。该检测采用SpeeDx市场领先的PlexPCR®复合技术，旨在检测代表10种病毒性呼吸道致病性病原体的14个靶点。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
Clik here to view.
BIO Announces Partnership with Taiwan BIO for 2019 Conference and Exhibition
WASHINGTON The Biotechnology Innovation Organization (BIO) announced today it will join the Taiwan Bio-Industry Organization (Taiwan BIO) to host BIO Asia-Taiwan from July 24-28 in Taipei, Taiwan....
View ArticleClik here to view.
Samsara Therapeutics Closes Seed Round Led by Apollo Ventures
NEW YORK & HAMBURG, Germany Samsara Therapeutics, Inc. (“Samsara,”) a platform biotechnology startup engaged in the discovery and development of compounds that address the primary molecular...
View ArticleClik here to view.
Gain Therapeuticsがパーキンソン病研究の有力財団からパーキンソン病向けの当社専有の非競合的分子シャペロンを発展させるための助成受領を発表
スイス・ルガーノ & スペイン・バルセロナ （ビジネスワイヤ） — GT Gain Therapeutics...
View ArticleClik here to view.
Alexion Employees Raise Hands to Raise Awareness and #RallyforRare on Rare...
BOSTON Alexion Pharmaceuticals, Inc. (Nasdaq:ALXN) is honored to support Rare Disease Day 2019 with the launch of #RallyforRare, a global social media campaign that aims to raise awareness of rare...
View ArticleClik here to view.
SpeeDxの販売ネットワークが中東に拡大
シドニー （ビジネスワイヤ） — SpeeDxは、UAE、サウジアラビア、オマーン、バーレーン、カタールにおけるResistancePlus®およびPlexPCR®の各検査キットの販売を目的に、Al Zahrawi Medical Supplies LLCを新しい提携先とする契約を締結したと発表しました。...
View ArticleClik here to view.
SpeeDx经销网络扩展至中东
悉尼 悉尼 (美国商业资讯) — SpeeDx Pty. Ltd.宣布与新合作伙伴Al Zahrawi Medical Supplies LLC签约，在阿联酋、沙特阿拉伯、阿曼、巴林和卡塔尔经销ResistancePlus®和PlexPCR®检测。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
ACT Genomics Opens Third Laboratory in Asia at Hong Kong Science Park
HONG KONG ACT Genomics Holdings Co., Ltd (“ACT Genomics” or the “Group”), a leading cancer precision treatment solution provider, yesterday opened its third Next Generation Sequencing (“NGS”)...
View ArticleClik here to view.
PhoreMost and inStem Enter Structural Biology Alliance
CAMBRIDGE, England PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has entered into a structural biology focussed...
View ArticleClik here to view.
Sengenics Partners with the Foundation for the National Institutes of Health...
SINGAPORE Sengenics, the functional proteomics company, today announced that it has joined the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium. As a member of the...
View Article